Goa K L, Benfield P
Adis International Limited, Auckland, New Zealand.
Drugs. 1994 Mar;47(3):536-66. doi: 10.2165/00003495-199447030-00009.
Hyaluronic acid is a naturally occurring polysaccharide with distinct physicochemical properties which underlie its application as a viscoelastic tool in ophthalmological surgery. In cataract surgery the role of hyaluronic acid in facilitating procedures and protecting the corneal endothelium is well established. Some benefit has also been gained with the use of hyaluronic acid in penetrating keratoplasty, trabeculectomy, retinal reattachment and trauma surgery, although its efficacy in these indications is less well-defined in the published literature. In addition to its lubricating and cushioning properties, demonstration of some in vitro anti-inflammatory activity and a possible disease-modifying effect for hyaluronic acid in animals has prompted its investigation as a treatment in osteoarthritis and, to a much lesser extent, in rheumatoid arthritis. Hyaluronic acid 20 mg, as weekly intra-articular injections for 3 to 7 weeks, improved knee pain and joint motion in patients with osteoarthritis. Although this occurred to a greater degree than with placebo in most comparisons, the effects of hyaluronic acid was similar to those of placebo in the largest trial. In the few available comparisons with other agents, hyaluronic acid appeared equivalent to methylprednisolone 40 mg (for 3 weeks) and to a single injection of triamcinolone 40 mg. Hyaluronic acid was distinguished from other therapies by providing a sustained effect after treatment discontinuation. Together with its very good tolerability profile, these properties justify further study of hyaluronic acid in patients with osteoarthritis. Some limited evidence of improvement in patients with rheumatoid arthritis, and a possible healing effect of hyaluronic acid on tympanic membrane perforations, represent additional areas of interest for future investigation. In summary, hyaluronic acid is a well-established adjunct to cataract surgery and may prove to be a promising option in the treatment of patients with osteoarthritis. Its very good tolerability provides further impetus for examination of its potential role in an extended scope of arthritic and ophthalmological indications, and in wound healing.
透明质酸是一种天然存在的多糖,具有独特的物理化学性质,这使其作为一种粘弹性工具在眼科手术中得到应用。在白内障手术中,透明质酸在促进手术操作和保护角膜内皮方面的作用已得到充分证实。在穿透性角膜移植术、小梁切除术、视网膜复位术和创伤手术中使用透明质酸也取得了一些益处,尽管其在这些适应症中的疗效在已发表的文献中定义得不太明确。除了其润滑和缓冲特性外,透明质酸在体外具有一定的抗炎活性,并且在动物实验中显示出可能的疾病改善作用,这促使人们对其作为骨关节炎治疗药物进行研究,在类风湿关节炎中的研究程度则要小得多。每周关节内注射20毫克透明质酸,持续3至7周,可改善骨关节炎患者的膝关节疼痛和关节活动度。尽管在大多数比较中,这种改善程度比安慰剂更大,但在最大规模的试验中,透明质酸的效果与安慰剂相似。在与其他药物的少数可用比较中,透明质酸似乎等同于40毫克甲基强的松龙(持续3周)和单次注射40毫克曲安奈德。透明质酸的独特之处在于停药后仍能产生持续效果。连同其非常好的耐受性,这些特性证明有必要对骨关节炎患者进一步研究透明质酸。类风湿关节炎患者有一些有限的改善证据,以及透明质酸对鼓膜穿孔可能的愈合作用,是未来研究的其他感兴趣领域。总之,透明质酸是白内障手术中公认的辅助药物,可能被证明是治疗骨关节炎患者的一个有前景的选择。其非常好的耐受性为研究其在更广泛的关节炎和眼科适应症以及伤口愈合中的潜在作用提供了进一步的动力。